Basic Information
ID: ALA5227023
Type: Functional
Description: Antiviral activity against recombinant HCoV-229E infected in MRC5 cells assessed as inhibition of plaque formation incubated upto 3 days by crystal violet staining based plaque-reduction assay
Organism: Human coronavirus 229E
Activity Charts
Bioactivity
Activity Types for Assay ALA5227023
IC50
Compound Summary
| Parent Molecular Weight | ALogP | Polar Surface Area |
|---|---|---|
| 507.43 | 4.30 | 4.30 |